Chemplast Sanmar (CHEMPLASTS) Q4 17/18 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 17/18 earnings summary
14 Oct, 2026Executive summary
FY18 delivered record pre-exceptional PBT of ₹393.22 crore, up 7% YoY; PAT rose to ₹178.61 crore from ₹150.24 crore.
Stronger Cuddalore volumes and margins, lower operating costs, and firm PVC prices supported results; reported sales are not comparable YoY because GST replaced excise duty from July 1, 2017.
Financial highlights
Sales and other income was ₹3,147.88 crore vs ₹3,290.98 crore; FY18 includes excise duty only through June 30, while GST is excluded.
EBITDA, reported as profit before interest, depreciation and taxes, was ₹545.84 crore vs ₹508.37 crore; interest was ₹77.26 crore and depreciation ₹75.36 crore.
PBT before exceptional items reached ₹393.22 crore vs ₹367.05 crore; after ₹27.67 crore of exceptional costs and taxes, PAT was ₹178.61 crore.
Basic and diluted EPS rose to ₹22.33 from ₹18.78; total comprehensive income was ₹178.63 crore.
Outlook and guidance
Prospects were described as bright, with healthy profits expected in coming years, mainly on the back of robust Indian PVC demand.
A 17,000 MT hydrogen peroxide plant at Mettur was expected to be commissioned in Q3 FY19.
Latest events from Chemplast Sanmar
- Chloromethanes margins lifted FY19 PBT as a major scheme reshaped the business.CHEMPLASTS
Q4 18/19 - EBITDA margin rose to 30.7%; consolidated profit included major investment-redemption gains.CHEMPLASTS
Q4 20/21 - Higher depreciation, finance costs and COVID-19 pressure drove a sharp FY20 profit decline.CHEMPLASTS
Q4 19/20 - Record FY22 performance and IPO-led deleveraging fund the next capacity-growth phase.CHEMPLASTS
Q4 21/22 - Price and energy pressure cut FY23 earnings as major growth projects advanced.CHEMPLASTS
Q4 22/23 - Revenue rose 2% YoY but EBITDA turned negative amid high costs and market pressures.CHEMPLASTS
Q1 26/27 - Q1 FY25 saw strong revenue and profit growth, led by specialty chemicals and CMC expansion.CHEMPLASTS
Q1 24/25 - FY25 revenue and EBITDA surged, led by specialty chemicals; net loss narrowed despite PVC headwinds.CHEMPLASTS
Q4 24/25 - Q1 FY26 saw a 4% YoY revenue drop, net loss, and one-time tax and revaluation impacts.CHEMPLASTS
Q1 25/26